In the present study, we have used elevated ALT as a marker for NAFLD and further demonstrated that the association between SGA and NAFLD differs by GA; SGA was associated with an increased risk for NAFLD among individuals with overweight or obesity born full-term, but not among those born preterm. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.